Paul Andrew Moore

Insider Reports History

Location
Vancouver, British Columbia, Canada
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Andrew Moore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. Chief Scientific Officer Restricted Stock Unit 53K $791K $14.92 10 Jan 2025 Direct
Zymeworks Inc. Chief Scientific Officer Common Stock 23.3K $348K $14.92 06 Jan 2025 Direct
Zymeworks Inc. Chief Scientific Officer Stock Option (Right to Buy) 200K 18 Jul 2022 Direct
Zymeworks Inc. Chief Scientific Officer Stock Option (Right to Buy) 79K 10 Jan 2025 Direct

Insider Reports Filed by Paul Andrew Moore

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 10 Jan 2025 2 $0 4 Chief Scientific Officer 10 Jan 2025, 18:07
ZYME Zymeworks Inc. 06 Jan 2025 6 -$316K 4 Chief Scientific Officer 06 Jan 2025, 20:35
ZYME Zymeworks Inc. 05 Jan 2024 6 -$106K 4 Chief Scientific Officer 08 Jan 2024, 18:01
ZYME Zymeworks Inc. 05 Jan 2023 2 $0 4 Chief Scientific Officer 06 Jan 2023, 19:00
ZYME Zymeworks Inc. 18 Jul 2022 1 $0 4 Chief Scientific Officer 19 Jul 2022, 21:05
ZYME Zymeworks Inc. 18 Jul 2022 0 $0 3 Chief Scientific Officer 19 Jul 2022, 21:00